Response to letter to the editor from min gong et al: "Risk for infections during treatment with denosumab for osteoporosis: A systematic review and meta-analysis"

Talia Diker-Cohen*, Dana Rosenberg, Tomer Avni, Daniel Shepshelovich, Gloria Tsvetov, Anat Gafter-Gvili

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)E403
JournalJournal of Clinical Endocrinology and Metabolism
Volume106
Issue number1
DOIs
StatePublished - 1 Jan 2021

Cite this